Lineage Cell Therapeutics (LCTX) Corporate Presentation from NobleCon18Research, News and Market Data on Lineage Cell TherapeuticsNobleCon 18 Complete Rebroadcast
|
Access to Exclusive Content. FREE for Registered Users Only.
Join the Channelchek Investor Community to access equity research, video content, events, and much more. All at no cost.
‌
Welcome to the Channelchek Investor Community
We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.
Don't have an account? Join
Forgot passwordBy clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.
Related News
‌
12/17/2024
Industrials
Release – Kratos Awarded $6.5 Million Contract to Provide Flight Testing for Hypersonic Research to Support Future Weapon Systems from DARPA
Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in Defense, National Security and Global Markets, was awarded a $6.5 million, single award contract by the Defense Advanced...
6 min read
‌
12/17/2024
Basic Materials
Release – LODE: Comstock Fuels Awarded $3 Million Fuel Incentive From Oklahoma
Comstock Inc. (NYSE: LODE) (“Comstock” or the “Company”) today announced that Comstock Fuels Corporation, (“Comstock Fuels”), an industry leader in extremely high yielding advanced lignocellulosic biomass refining solutions, including sustainable...
8 min read
‌
12/17/2024
Industrials
Release – The GEO Group Announces $70 Million Investment in Expanding ICE Services Capabilities and New Corporate Reorganization
The GEO Group, Inc. (NYSE: GEO) (“GEO” or the “Company”) announced today a $70 million investment in capital expenditures to strengthen the Company’s capabilities to deliver expanded detention capacity, secure...
6 min read
Inbox Intel from Channelchek.
Informed investors make more money. And it’s all about timing. Get it when it happens.